Recursion Pharmaceuticals (RXRX) EBT Margin Growth (1y) (2021 - 2026)
Recursion Pharmaceuticals (RXRX) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.59 Bn | 933.22 Mn | -6.02 Mn | -51,238.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51,238.00 |
| Dec 31, 2025 | 363,112.00 |
| Sep 30, 2025 | -276,844.00 |
| Jun 30, 2025 | -21,404.00 |
| Mar 31, 2025 | -70,627.00 |
| Dec 31, 2024 | -304,413.00 |
| Sep 30, 2024 | 51,628.00 |
| Jun 30, 2024 | 1,624.00 |
| Mar 31, 2024 | -12,968.00 |
| Dec 31, 2023 | -41,925.00 |
| Sep 30, 2023 | -40,752.00 |
| Jun 30, 2023 | 16,629.00 |
| Mar 31, 2023 | 51,159.00 |
| Dec 31, 2022 | 209,322.00 |
| Sep 30, 2022 | 136,428.00 |
| Jun 30, 2022 | 84,109.00 |
| Mar 31, 2022 | 14,979.00 |
| Dec 31, 2021 | -160,836.00 |
| Sep 30, 2021 | 39,185.00 |
| Jun 30, 2021 | 831,931.00 |